Compare Cytokinetics Inc (CYTK) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs SMX Security Matters plc — how do they compare? Cytokinetics Inc trades at $81.56 (market cap $11.12B), while SMX Security Matters plc trades at $17.5 (market cap $17.11M). The key difference: Cytokinetics Inc is far larger — about 649.9× SMX Security Matters plc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| CYTK | SMX | |
|---|---|---|
Market Cap | $11.12B | $17.11M |
Sector | Technology | Technology |
52-Week High | $87.26 | $295.56K |
52-Week Low | $33.23 | $12.87 |
Enterprise Value | $11.59B | $14.08M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $82.24, down 3.1% today, with a bullish technical outlook supported by moving averages and RSI near oversold levels. The company shows strong analyst support with 97% buy ratings and a $110.40 consensus target, but faces fundamental challenges with a -784% net income margin and negative cash flow from operations of -$510M in 2025. Recent positive developments include FDA approval and European launch of Myqorzo, driving commercial momentum.
Outlook remains speculative with high valuation (P/S 93.92) against significant losses, yet growth potential exists if Myqorzo gains market traction. Key risks include cash burn, competitive pressure, and reliance on single drug success. Institutional sentiment is overwhelmingly bullish, but investors must weigh high risk-reward profile amid ongoing profitability challenges.
SMX trades at $16.21, up 3.58% today, amid neutral technical signals and recent reverse stock splits. The company is positioning itself in the recycling technology space with its Circularity-as-a-Service platform, targeting demand from new state recycling mandates. However, financial metrics show significant challenges with negative ROE of -2,216.26% and ROA of -398.22%, indicating substantial profitability concerns despite a reasonable P/B ratio of 1.93.
The outlook remains speculative with potential upside from regulatory tailwinds in recycling verification technology, but high execution risk given current negative profitability. Investors face substantial dilution risk from recent reverse splits and need to monitor the company's ability to convert regulatory opportunities into sustainable revenue growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
